A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseStephen Salloway, Michael GrundmanNeurologyNovember 19, 200910.1212/wnl.0b013e3181c67808Cited by 736SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis